Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2018-07-19 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HARNES (62440), Pas-de-Calais
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU BIEN ETRE : revenue, balance sheet and financial ratios
PHARMACIE DU BIEN ETRE is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HARNES (62440),
this company of category PME
shows in 2024 a net income positive of 97 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU BIEN ETRE (SIREN 841200512)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
96 518 €
123 311 €
205 187 €
180 620 €
140 601 €
21 155 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DU BIEN ETRE generates positive net income of 97 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 21 k€ -> 97 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
96 518 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 50%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
50.151%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
59.331%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU BIEN ETRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
493.399
271.477
160.751
101.754
68.717
50.151
Financial autonomy
15.066
23.878
34.168
45.116
54.113
59.331
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
50.152024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good-11 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU BIEN ETRE (50.15) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
59.33%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+15 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU BIEN ETRE (59.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 191.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
191.509
Liquidity indicators evolution PHARMACIE DU BIEN ETRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
233.239
235.326
0.0
0.0
0.0
191.509
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
191.512024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good+51 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU BIEN ETRE (191.51) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DU BIEN ETRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU BIEN ETRE is estimated at
1 347 462 €
(range 938 351€ - 2 015 881€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
938k€1347k€2015k€
1 347 462 €Range: 938 351€ - 2 015 881€
NAF 5 année 2024
Valuation method used
Net Income Multiple
96 518 €
×
14.0x
=1 347 463 €
Range: 938 352€ - 2 015 881€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU BIEN ETRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU BIEN ETRE
What is the revenue of PHARMACIE DU BIEN ETRE ?
The revenue of PHARMACIE DU BIEN ETRE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU BIEN ETRE profitable?
Yes, PHARMACIE DU BIEN ETRE generated a net profit of 97 k€ in 2024.
Where is the headquarters of PHARMACIE DU BIEN ETRE ?
The headquarters of PHARMACIE DU BIEN ETRE is located in HARNES (62440), in the department Pas-de-Calais.
Where to find the tax return of PHARMACIE DU BIEN ETRE ?
The tax return of PHARMACIE DU BIEN ETRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU BIEN ETRE operate?
PHARMACIE DU BIEN ETRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart